Sentinel node staging of resectable colon cancer: results of a multicenter study.
Sentinel node staging of resectable colon cancer: results of a multicenter study.
复制标题
可切除结肠癌的前哨淋巴结分期:多中心研究的结果。
DOI:
10.1097/01.sla.0000140753.41357.20
复制
发表时间:
2004
影响因子:
9
通讯作者:
Compton,Carolyn
中科院分区:
文献类型:
--
作者:
Bertagnolli,Monica;Miedema,Brent;Redston,Mark;Dowell,Jeannette;Niedzwiecki,Donna;Fleshman,James;Bem,Jiri;Mayer,Robert;Zinner,Michael;Compton,Carolyn
Methods:SN sampling involved peritumor injection of 1% isosulfan blue, followed by identification of all LN visualized within 10 minutes. SN sampling was performed on 79 of 91 patients enrolled, followed by multilevel sectioning (MLS) of the nodes and examination by a single study pathologist.Results:By standard histopathology, 7 patients had primary disease that was either benign or not colon cancer and were therefore excluded from further studies. Of 72 colon cancer cases studied, 48 (66%) were node-negative and 24 (33%) contained nodal metastases. SNs were successfully located in 66 cases (92%), with an average of 2.1 nodes per patient. SNs were negative in 14 of 24 node-positive cases (58%). MLS revealed tumor in a SN in 1 of these cases, bringing the false-negative rate of SN examination to 54%.Conclusion:This multi-institutional study found that for patients with node-positive colon cancer, SN examination with MLS failed to predict nodal status in 54% of cases. We conclude that SN sampling with MLS, used alone, is unlikely to improve risk stratification for resectable colon cancer.